Drug-SNPing: An integrated drug-based, protein interaction-based tagSNP-based pharmacogenomics platform for SNP genotyping

Bioinformatics

Volumn 29, Issue 6, 2013, Pages 758-764

  Yang, Cheng Hong ^a   Cheng, Yu Huei ^b   Chuang, Li Yeh ^c   Chang, Hsueh Wei ^d,e,f  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b TOKO UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d Department of Biomedical Science and Environmental Biology ^*  (Taiwan)

^e Graduate Institute of Natural Products   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER INTERFACE; COMPUTER PROGRAM; GENETIC DATABASE; GENOTYPING TECHNIQUE; HAPLOTYPE MAP; HUMAN; INTERNET; METHODOLOGY; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEM ANALYSIS;

DATABASES, GENETIC; GENOTYPING TECHNIQUES; HAPMAP PROJECT; HUMANS; INTERNET; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN INTERACTION MAPPING; SOFTWARE; SYSTEMS INTEGRATION; USER-COMPUTER INTERFACE;

EID: 84875154944     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt037     Document Type: Article

References (68)

1. Andre Bauer,R. et al. (2008) SuperSite: dictionary of metabolite and drug binding sites in proteins. Nucleic Acids Res., 37, D195-D200.
2. Bao,H. et al. (2009) MapNext: a software tool for spliced and unspliced alignments and SNP detection of short sequence reads. BMC Genomics, 10 (Suppl. 3), S13.
3. Beckstead,W.A. et al. (2008) SNP2RFLP: a computational tool to facilitate genetic mapping using benchtop analysis of SNPs. Mamm. Genome, 19, 687-690.
4. Burgarella,S. et al. (2005) MicroGen: a MIAME compliant web system for microarray experiment information and workflow management. BMC Bioinformatics, 6 (Suppl. 4), S6.
5. Burgoon,L.D. et al. (2006) dbZach: aMIAME-compliant toxicogenomic supportive relational database. Toxicol. Sci., 90, 558-568.
6. Chang,H.W. et al. (2006) SNP-RFLPing: restriction enzyme mining for SNPs in genomes. BMC Genomics, 7, 30.
7. Chang,H.W. et al. (2009a) Seq-SNPing: multiple-alignment tool for SNP discovery, SNP ID identification, and RFLP genotyping. OMICS, 13, 253-260.
8. Chang,H.W. et al. (2009b) Prim-SNPing: a primer designer for cost-effective SNP genotyping. Biotechniques, 46, 421-431.
9. Chang,H.W. et al. (2010) SNP-RFLPing 2: an updated and integrated PCR-RFLP database tool for SNP genotyping. BMC Bioinformatics, 11, 173.
10. Chang,H.W. et al. (2012) The importance of integrating SNP and cheminformatics resources to pharmacogenomics. Curr. Drug Metab., 13, 991-999.
11. Chen,X. and Sullivan,P.F. (2003) Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput. Pharmacogenomics J., 3, 77-96.
12. Chen,J. et al. (2005) ChemDB: a public database of small molecules and related chemoinformatics resources. Bioinformatics, 21, 4133-4139.
13. Chuang,L.Y. et al. (2008) Restriction enzyme mining for SNPs in genomes. Anticancer Res., 28, 2001-2007.
14. Daly,A.K. (2010) Genome-wide association studies in pharmacogenomics. Nat. Rev., 11, 241-246.
15. Deloukas,P. and Bentley,D. (2004) The HapMap project and its application to genetic studies of drug response. Pharmacogenomics J., 4, 88-90.
16. Demirci,F.Y. et al. (2007) Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J. Rheumatol., 34, 1708-1711.
17. Field,H.I. et al. (2009) Seq4SNPs: new software for retrieval of multiple, accurately annotated DNA sequences, ready formatted for SNP assay design. BMC Bioinformatics, 10, 180.
18. Freimuth,R.R. et al. (2005) PolyMAPr: programs for polymorphism database mining, annotation, and functional analysis. Hum. Mutat., 25, 110-117.
19. Gong,L. et al. (2008) PharmGKB: an integrated resource of pharmacogenomic data and knowledge. Curr. Protoc. Bioinformatics, Chapter 14, Unit14.17.
20. Hayes,K.R. et al. (2005) EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol. Pharmacol., 67, 1360-1368.
21. Hug,H. et al. (2003) ADRIS-the adverse drug reactions information scheme. Pharmacogenetics, 13, 767-772.
22. Ikin,A. et al. (2010) The Gene Interaction Miner: a new tool for data mining contextual information for protein-protein interaction analysis. Bioinformatics, 26, 283-284.
23. Jensen,L.J. et al. (2009) STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res., 37, D412-D416.
24. Ji,Z.L. et al. (2003) Drug Adverse Reaction Target Database (DART): proteins related to adverse drug reactions. Drug Saf., 26, 685-690.
25. Knox,C. et al. (2011) DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Res., 39, D1035-D1041.
26. Kocsis,A.K. et al. (2008) Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand. J. Gastroenterol., 43, 299-307.
27. Kuhn,M. et al. (2010) STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res., 38, D552-D556.
28. Kundrotas,P.J. et al. (2010) GWIDD: genome-wide protein docking database. Nucleic Acids Res., 38, D513-D517.
29. Lehne,B. and Schlitt,T. (2009) Protein-protein interaction databases: keeping up with growing interactomes. Hum. Genomics, 3, 291-297.
30. Lin,G.T. et al. (2008) SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women. Chin. J. Physiol., 91, 1-10.
31. Lin,G.T. et al. (2009) Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS, 13, 165-172.
32. Liu,Y. et al. (2010) DCDB: drug combination database. Bioinformatics, 26, 587-588.
33. Masciocchi,J. et al. (2009) MMsINC: a large-scale chemoinformatics database. Nucleic Acids Res., 37, D284-D290.
34. Mattingly,C.J. et al. (2003) The Comparative Toxicogenomics Database (CTD). Environ. Health Perspect., 111, 793-795.
35. Mattingly,C.J. et al. (2006) The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. J. Exp. Zool. A Comp. Exp. Biol., 305, 689-692.
36. Mechanic,L.E. et al. (2008) Polymorphism Interaction Analysis (PIA): a method for investigating complex gene-gene interactions. BMC Bioinformatics, 9, 146.
37. Miteva,M.A. et al. (2006) FAF-Drugs: free ADME/tox filtering of compound collections. Nucleic Acids Res., 34, W738-W744.
38. Neugebauer,A. et al. (2007) Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods. J. Med. Chem., 50, 4665-4668.
39. Owen,R.P. et al. (2008) PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum Mutat, 29, 456-460.
40. Packer,B.R. et al. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34, D617-D621.
41. Peters,E.J. and McLeod,H.L. (2008) Ability of whole-genome SNP arrays to capture 'must have' pharmacogenomic variants. Pharmacogenomics, 9, 1573-1577.
42. Roberts,R.J. et al. (2010) REBASE-a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Res., 38, D234-D236.
43. Royo,J.L. and Galan,J.J. (2009) Pyrosequencing for SNP genotyping. Methods Mol. Biol., 578, 123-133.
44. Salter,A.H. (2005) Large-scale databases in toxicogenomics. Pharmacogenomics, 6, 749-754.
45. Sangkuhl,K. et al. (2008) PharmGKB: understanding the effects of individual genetic variants. Drug Metab. Rev., 40, 539-551.
46. Schmitt,A.O. et al. (2010) CandiSNPer: a web tool for the identification of candidate SNPs for causal variants. Bioinformatics, 26, 969-970.
47. Shen,G.Q. et al. (2009) The TaqMan method for SNP genotyping. Methods Mol. Biol., 578, 293-306.
48. Sherry,S.T. et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res., 29, 308-311.
49. Sun,L.Z. et al. (2002) ADME-AP: a database of ADME associated proteins. Bioinformatics, 18, 1699-1700.
50. Thorisson,G.A. et al. (2005) The International HapMap Project Web site. Genome Res., 15, 1592-1593.
51. Thorn,C.F. et al. (2010) Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics, 11, 501-505.
52. Timmers,L.F. et al. (2008) Drug-binding databases. Curr. Drug Targets, 9, 1092-1099.
53. Tong,W. et al. (2003) ArrayTrack-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ. Health Perspect., 111, 1819-1826.
54. Voisey,J. and Morris,C.P. (2008) SNP technologies for drug discovery: a current review. Curr. Drug Discov. Technol., 5, 230-235.
55. Wang,H. et al. (2007) Chemical data mining of the NCI human tumor cell line database. J. Chem. Inf. Model., 47, 2063-2076.
56. Wegrzyn,J.L. et al. (2009) PineSAP-sequence alignment and SNP identification pipeline. Bioinformatics, 25, 2609-2610.
57. Wishart,D.S. (2007) In silico drug exploration and discovery using DrugBank. Curr. Protoc. Bioinformatics, Chapter 14, Unit 14.14.
58. Wishart,D.S. (2008) DrugBank and its relevance to pharmacogenomics. Pharmacogenomics, 9, 1155-1162.
59. Wishart,D.S. et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 36, D901-D906.
60. Xirasagar,S. et al. (2006) Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application. Bioinformatics, 22, 874-882.
61. Yang,C.H. et al. (2008) SNP ID-info: SNP ID searching and visualization platform. OMICS, 12, 217-226.
62. Yang,C.H. et al. (2009) Novel generating protective single nucleotide polymorphism barcode for breast cancer using particle swarm optimization. Cancer Epidemiol., 33, 147-154.
63. Yang,C.H. et al. (2012) Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms. Kaohsiung J. Med. Sci., 28, 362-368.
64. Yen,C.Y. et al. (2008) Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J. Oral Pathol. Med., 37, 271-277.
65. Yoshiya,G. et al. (2008) Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J. Gastroenterol. Hepatol., 23, 948-953.
66. Zamar,D. et al. (2009) Path: a tool to facilitate pathway-based genetic association analysis. Bioinformatics, 25, 2444-2446.
67. Zheng,C.J. et al. (2007) PharmGED: pharmacogenetic effect database. Nucleic Acids Res., 35, D794-D799.
68. Zheng,S.L. et al. (2008) Cumulative association of five genetic variants with prostate cancer. N Engl. J. Med., 358, 910-919.